Digital channels for collecting data on adverse drug events

2021-06-20T17:12:06+03:00

Following the rules of good practice for pharmacovigilance of the Eurasian Economic Union, one of the processes for documenting the critical process of working with HP at the manufacturer of medicinal products, which should be reflected in the Master File of the FN System (MFSF) - the main document of the pharmacovigilance system, is the [...]

Digital channels for collecting data on adverse drug events2021-06-20T17:12:06+03:00

Information channels in the formation of the pharmacovigilance system

2021-06-10T23:23:53+03:00

The development of information channels for improving the processes of monitoring and analyzing information on the safety of medicinal products is an important critical process of pharmacovigilance and the duty of the authorized person for pharmacovigilance (FDA) at the manufacturer of medicinal products. As part of the effective implementation of this routine process in the [...]

Information channels in the formation of the pharmacovigilance system2021-06-10T23:23:53+03:00
Go to Top